Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Within 1 year, 15% of Canadian patients with severe asthma discontinue benralizumab. The reasons for discontinuation are not yet characterised. https://bit.ly/3kaRDlp.

authors

  • Noorduyn, Stephen G
  • Johnston, Karissa
  • Osenenko, Kathy
  • Sriskandarajah, Niroshan
  • Gendron, Alain
  • Mbuagbaw, Lawrence

publication date

  • October 2021